Ulcerative colitis: open trials in Hungary

18 open trials have a site in Hungary. Registry data; only the trial team decides who can take part.

2023-507853-13-00
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly & Co.
Semmelweis Egyetem, Budapest · Obudai Egeszseguegyi Centrum Kft., Budapest III · Clinexpert Kft., Budapest III · Clinexpert Gyoengyoes Kft., Gyongyos · University of Szeged, Szeged · Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz, Szekesfehervar
Registry updated 2026-11-05
NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
Semmelweis Egyetem, Budapest · Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged · CLINFAN Szolgáltató Kft, Szekszárd
Registry updated 2026-11-04
NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Trial Treatment · Phase 2 · Eli Lilly and Company
Békés Megyei Központi Kórház - dr. Réthy Pál Tagkórház, Békéscsaba · Semmelweis Egyetem, Budapest · Óbudai Egészségügyi Centrum, Budapest · Pannonia Maganorvosi Centrum, Budapest · Clinexpert Gyongyos, Gyöngyös · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya · Javorszky Odon Korhaz, Vác
Registry updated 2026-11-04
NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly and Company
Óbudai Egészségügyi Centrum, Budapest · Semmelweis University, Budapest · Clinexpert Gyongyos, Gyöngyös · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya
Registry updated 2026-11-04
NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
Semmelweis University, Budapest · Geomedical Kft., Budapest VI · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya
Registry updated 2026-11-04
NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Semmelweis University, Budapest
Registry updated 2026-11-03
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Semmelweis University, Budapest · Obudai Egeszseguegyi Centrum Kft., Budapest III · Semmelweis University, Budapest VIII · Pannonia Maganorvosi Centrum Kft., Budapest XIII · University of Szeged, Szeged
Registry updated 2026-11-03
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Obudai Egeszseguegyi Centrum Kft., Budapest III · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Semmelweis University, Budapest VIII · Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz, Szekesfehervar
Registry updated 2026-11-03
NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Trial Treatment · Phase 1/2 · Xencor, Inc.
Budapest · Nyíregyháza · Vác
Registry updated 2026-10-30
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Obudai Egeszseguegyi Centrum Kft., Budapest III · Central Hospital Of Northern Pest Military Hospital, Budapest VI · Semmelweis University, Budapest VIII · Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz, Szekesfehervar
Registry updated 2026-10-27
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Budapest · Eger
Registry updated 2026-10-23
2025-524404-29-00
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
Trial Treatment · Phase 2 · Eli Lilly & Co.
Obudai Egeszseguegyi Centrum Kft., Budapest III · Semmelweis University, Budapest VIII · Clinexpert Gyoengyoes Kft., Gyongyos · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya
Registry updated 2026-10-21
NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Palisade Bio
Site HU-005, Budapest · Site HU-002, Budapest · Site HU-001, Budapest · Site HU-004, Debrecen · Site HU-007, Gyöngyös · Site HU-006, Tatabánya · Site HU-003, Veszprém
Registry updated 2026-10-21
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Budapest · Budapest · Veszprém
Registry updated 2026-10-16
2025-522338-30-00
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Trial Treatment · Phase 2 · Eli Lilly & Co.
Bekes Varmegyei Koezponti Korhaz, Bekescsaba · Obudai Egeszseguegyi Centrum Kft., Budapest III · Semmelweis University, Budapest VIII · Pannonia Maganorvosi Centrum Kft., Budapest XIII · Clinexpert Gyoengyoes Kft., Gyongyos · Komarom-Esztergom Varmegyei Szent Borbala Korhaz, Tatabánya · Javorszky Oedoen Korhaz, Vac
Registry updated 2026-10-07
2024-520201-39-00
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics Inc.
Semmelweis University, Budapest VIII · University of Szeged, Szeged
Registry updated 2026-07-31
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial Treatment · Phase 2 · Takeda
Semmelweis University, Budapest · Clinexpert Kft., Budapest III · Pannonia Maganorvosi Centrum Kft., Budapest XIII · EURO-ENDO-MED Kft., Mohács
Registry updated 2026-05-22
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Clinexpert Kft., Budapest III · Semmelweis University, Budapest VIII · Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz, Miskolc
Registry updated 2026-05-07

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error